期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

水化治疗预防冠状动脉介入术后造影剂肾病的现状及护理进展 被引量：5

下载PDF
导出
摘要 造影剂肾病（contrast induced nephropathy,CIN）是使用碘化造影剂后常见的严重并发症。据国外数据统计,整体人群中造影剂肾病的发病率为1%～2%,而冠心病患者接受PCI术后CIN发生率为10%～20%,高危患者更是高达30%～40%。国内研究报道中,也得出相似结论。常文雄等研究显示,冠心病患者冠状动脉术后CIN发生率为10.83%,而朱志勇等对有肾功能不全的患者冠状动脉术后CIN发生率为23.08%。水化治疗是使用最早、目前被广泛接受的有效减少造影剂肾病发生率的方法。
作者 龚晓霞 郭春芳
机构地区 江苏省无锡市人民医院心内科
出处 《护理实践与研究》 2011年第21期113-114,共2页 Nursing Practice and Research
关键词 造影剂肾病 介入术后 冠状动脉 水化治疗 冠心病患者 护理 预防 严重并发症
分类号 R473.5 [医药卫生—护理学]
  • 相关文献

参考文献22

  • 1Morcos SK.Contrast Media-induced Nephrotoxicity-questions and Answers[J].Br J Radiol,1998,7l(844):357-365.
  • 2BarreItr BJ,Parfeu PS.Clinical practice:prevent-ing nephropathy induced by contrast medium[J].N Engl JMed,2006,354(4):379-386.
  • 3Rihal CS,Textor SC,Grili DE,et al.Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention[J].Circulation,2002,105:2259-2264.
  • 4Wonggtc,Irwinmg,Wonggtc,et al.Contrast-induced nephropathy[J].Br J Anaesth,2007,99:474-483.
  • 5常文雄,万招飞,高智耀.冠心病患者冠脉介入术后发生造影剂肾病的危险因素分析[J].昆明医学院学报,2010,31(7):93-96. 被引量：8
  • 6朱志勇,周庆国,王轶.冠心病患者对比剂诱发肾病的临床研究[J].中国医药导报,2010,7(19):235-235. 被引量：6
  • 7潘立群,茅文辉.水化治疗联合NAC预防造影剂肾病60例围术期护理[J].齐鲁护理杂志（下半月刊）（外科护理）,2010,16(11):81-82. 被引量：7
  • 8Hariprasad S.Trivedi Harold Moore.A Randomized Prospeetive Trial to Assess the Role of Saline Hydration on the Development of Contrast Nephrotoxicity[J].Nephron Clin Pract,2003,93:29-34.
  • 9Stevens MA,Mcullough PA,Tobin KJ.A prospective randomized trail of prevention measures in patients at high risk for contrast nrphropathy[J].J Am Coll Cardiol,1999,33(2):403-411.
  • 10Mueller C,Buerkle G,Buettner H,et al.Prevention of contrast media-associated nepbropathy[J].Arch Intern Med,2002,162:329-336.

二级参考文献86

共引文献127

同被引文献43

  • 1甘平,黄烨,黄华梅.心血管介入术后迷走神经反射相关因素分析与护理体会[J].世界最新医学信息文摘,2020(36):51-52. 被引量：1
  • 2侯湘岭,刘慧,王伟红,陈伟,付晨阳.不同水化方法对冠状动脉介入术后造影剂肾病的临床观察[J].中华临床医师杂志（电子版）,2011,5(13):3968-3970. 被引量：18
  • 3Bashore TM,Bates ER,Berger PB,et d.Catheterization laboratory standards : a report of the american college of cardiology task force on clinical expert consensus documents[J].J Am Coil Cardiol,2001,37 (8) :2170-2214.
  • 4Trivedi HS,Moore H,Nasr S,et al.A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity[J].Nephron Clin Pract, 2003,93 ( 1 ) : C29-C34.
  • 5Stacul F, van der Molen A J, Reimer P, et al. Contrast in- duced nephropathy: updated ESUR contrast media safety com- mittee guidelines[ J]. Eur Radio, 2011, 21 (12) : 2527.
  • 6Seeliger E, Sendeski M, Rihal C S, et al. Contrast-induced kidney injury : mechanisms, risk factors, and prevention [ J ]. Eur Heart J, 2012, 33(16): 2007.
  • 7Marenzi G, Ferrari C, Marana I, et al. Prevention of contrast nephropathy by furoscmide with matched hydration: the MYTHOS ( Induced diuresis with matched hydration compared to standard hydration for contrast induced nephropathy preven- tion) trial[ J]. JACC Cardiovasc Interv, 2012, 5 ( 1 ) : 90.
  • 8Rundback J H,Nahl D, Yoo V. Contrast-induced nephropa- thy[J]. Journal of vascular surgery, 2011, 54(2) : 575.
  • 9Patti G, Nusca A, Chello M, et al. Usefulness of statin pre- treatment to prevent contrast-induced nephropathy and to im- prove long-term outcome in patients undergoing percutaneous coronary intervention [ J ]. Am J Cardiol, 2008, 101 ( 3 ) : 279.
  • 10Patti G, Rieottini E, Nusea A, et al. Short-Term, High-Dose Atorvastatin Pretreatment to Prevent Contrast-Induced Ne- phropathy in Patients With Acute Coronary Syndromes Under- going Percutaneous Coronary Intervention (from the ARMY- DA-CIN [ Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Contrast-Induced Nephropathy] Trial[ J]. The American journal of cardiology, 2011, 108( 1 ) : 1.

引证文献5

二级引证文献8

护理实践与研究
2011年 第21期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部